GPE
Septerna Embarks on IPO Journey with Promising Preclinical Data and Vision to Revolutionize GPCR Drug Discovery
Septerna, IPO, GPCR, preclinical data, drug discovery, biotechnology, PTH1R agonists, hypoparathyroidism
Eli Lilly Invests $4.5 Billion in Groundbreaking Indiana Manufacturing and R&D Facility
Eli Lilly, pharmaceutical manufacturing, R&D, Indiana, Lilly Medicine Foundry, clinical trials, drug development
Pharmaceutical Giants J&J and Bayer Announce Layoffs of Nearly 300 Employees in New Jersey
Johnson & Johnson, Bayer, layoffs, New Jersey, pharmaceutical industry, job cuts
Big Pharma’s Layoff Wave Continues in New Jersey: J&J and Bayer Announce Significant Job Cuts
Big Pharma layoffs, New Jersey, Johnson & Johnson, Bayer, pharmaceutical industry restructuring
UK Regulator Approves Pharming’s Joenja for Rare Immune Disorder APDS, Leveraging FDA Review
Joenja, leniolisib, APDS, MHRA approval, FDA review, rare immune disorder, Pharming
Sanofi Receives Bids from Private Equity Firms for $16B+ Consumer Health Business
Sanofi, private equity firms, consumer health business, PAI Partners, Clayton, Dubilier & Rice, Bloomberg
Headlands Research Expands with New Clinical Trial Site in El Paso, Texas
Headlands Research, clinical trial site, El Paso, Texas, diversity in clinical research, clinical trials, medical research
AI Guidance for Investors: Navigating the Future with Strategic Approaches and Regulatory Insights
AI Guidance for Investors, Strategic AI Adoption, Regulatory Impact on AI, Cybersecurity Risks in AI, AI Mapping Strategies, Data Governance in AI, Future of AI in Healthcare
Bristol Myers Squibb Continues Layoffs in New Jersey, Cutting 79 More Jobs
Bristol Myers Squibb, BMS layoffs, New Jersey layoffs, pharmaceutical industry layoffs, cost-savings measures
Bristol Myers Squibb Continues Layoffs, Cutting 79 More Jobs in New Jersey Amid $1.5B Cost Reduction Effort
Bristol Myers Squibb, layoffs, New Jersey, cost reduction, pharmaceutical industry